FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 354:636-638 February 9, 2006 Number 6 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Chambers, C. D. PubMed Citation

Persistent pulmonary hypertension of the newborn (PPHN) is a serious condition that typically occurs in full-term or near-term infants. Before birth, the fetus receives oxygenated blood from the placenta; a high pulmonary arterial pressure results in low blood flow to the lungs and shunting of the oxygenated blood to the systemic circulation through the foramen ovale and the ductus arteriosus. PPHN occurs when pulmonary arterial pressure remains high after birth and poorly oxygenated blood continues to be shunted to the systemic circulation. In one study involving 155 full-term newborns with moderately severe PPHN, 11 died, and nearly half the survivors . . . [Full Text of this Article]

Source Information

From the National Institute of Child Health and Human Development, Bethesda, Md.

This article has been cited by other articles:

• Reefhuis, J., Rasmussen, S. A., Friedman, J. M., Hallberg, P., Odlind, V., Sjoblom, V., Chambers, C., Hernandez-Diaz, S., Mitchell, A. A. (2006). Selective serotonin-reuptake inhibitors and persistent pulmonary hypertension of the newborn.. NEJM 354: 2188-2190 [Full Text]  
• (2006). SSRIs and Persistent Pulmonary Hypertension in Newborns. Journal Watch Cardiology 2006: 4-4 [Full Text]